Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Medicines Discovery Catapult

Research Institution/University

md.catapult.org.uk/drug-discovery/modalities/radiopharmaceuticals/Macclesfield, United Kingdom

About

Medicines Discovery Catapult (MDC) accelerates drug discovery through collaborative R&D, providing a specialized platform to transition Radiopharmaceutical Therapy (RPT) from concept to clinical readiness. MDC's RPT focus includes radiochemistry, dosimetry, advanced translational imaging, and validation via patient-derived tumor models (PDX). For more details, visit Medicines Discovery Catapult.

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Lynne Braidwood

Business Development Manager

Medicines Discovery Catapult

Marketplace (1)

  • Partnership

    Radiopharmaceutical preclinical studies

    If you are interested in running pre clinical studies using your targeted company, we can radiolabel it with Lu177, Ac225 or other isotopes and run the Biodistribution, effacacy and diameter studies required to move your asset along the pipeline

    Author

    Lynne Braidwood

    Business Development Manager at Medicines Discovery Catapult

    Macclesfield, United Kingdom